Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com

StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued on Thursday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Up 2.2 %

ENZ stock opened at $0.74 on Thursday. Enzo Biochem has a twelve month low of $0.68 and a twelve month high of $1.44. The firm’s fifty day simple moving average is $0.97 and its two-hundred day simple moving average is $1.07.

Enzo Biochem (NYSE:ENZ) last issued its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 81.73% and a negative return on equity of 11.84%.

Hedge Funds Weigh In On Enzo Biochem

Hedge funds have recently added to or reduced their stakes in the stock. XTX Topco Ltd lifted its holdings in shares of Enzo Biochem by 94.5% in the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after buying an additional 13,735 shares during the period. BBR Partners LLC purchased a new stake in Enzo Biochem in the third quarter worth about $112,000. Geode Capital Management LLC grew its holdings in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares in the last quarter. Finally, Renaissance Technologies LLC increased its position in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after purchasing an additional 64,417 shares during the period. 36.90% of the stock is currently owned by institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.